Royal Bank of Canada
INM icon

Royal Bank of Canada’s InMed Pharmaceuticals INM Stock Holding History

Royal Bank of Canada’s Portfolio INM Stock Details INM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1
Closed – – 7064
2024
Q3 		$0 Hold
1
– – ﹤0.01% 7117
2024
Q2 		$0 Hold
1
– – ﹤0.01% 7278
2024
Q1 		$0 Hold
1
– – ﹤0.01% 7269
2023
Q4 		$0 Hold
1
– – ﹤0.01% 7331
2023
Q3 		$0 Hold
1
– – ﹤0.01% 7314
2023
Q2 		$0 Hold
1
– – ﹤0.01% 7431
2023
Q1 		$0 Hold
1
– – ﹤0.01% 7257
2022
Q4 		$0 Buy
+1
New +$67 ﹤0.01% 7450
2022
Q3 		– Sell
-1
Closed -$185 – 7625
2022
Q2 		$0 Hold
1
– – ﹤0.01% 7528
2022
Q1 		$0 Hold
1
– – ﹤0.01% 7865
2021
Q4 		$1K Hold
1
– – ﹤0.01% 7505
2021
Q3 		$0 Hold
1
– – ﹤0.01% 7734
2021
Q2 		$1K Hold
1
– – ﹤0.01% 7313
2021
Q1 		$2K Buy
+1
New +$2.15K ﹤0.01% 7238
2020
Q4 		– Hold
0
– – – 6946

Other funds holding INM

AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AWM
AllSquare Wealth Management Albany, New York $189M AUM 14.89% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $41.5B AUM 29.19% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Royal Bank of Canada's INM Position: Q4 2024 in Review

Royal Bank of Canada sold out of InMed Pharmaceuticals (INM) in Q4 2024, closing a stake of 1 share.

Royal Bank of Canada first reported a position in INM in Q1 2021 and held it in 14 quarters. The position peaked at $2K in Q1 2021. 5 funds tracked by Wall St. Rank hold INM as of Q4 2024.

  • Royal Bank of Canada reported no remaining InMed Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Royal Bank of Canada sold 1 InMed Pharmaceuticals share in Q4 2024.
  • Royal Bank of Canada first reported a position in InMed Pharmaceuticals in Q1 2021 and held it in 14 quarters.
  • Royal Bank of Canada's InMed Pharmaceuticals position peaked at $2K in Q1 2021.
  • 5 funds tracked by Wall St. Rank held InMed Pharmaceuticals as of Q4 2024.

Based on Royal Bank of Canada's 13F filing for Q4 2024, filed 14 Feb 2025.